CI Investments Inc
MRNA icon

CI Investments Inc’s Moderna MRNA Stock Holding History

CI Investments Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$855K Buy
+12,208
New +$632K ﹤0.01% 563
2025
Q4 		– Sell
-3,090
Closed -$80K – 1031
2025
Q3 		$80K Sell
3,090
-2,042
-40% -$57K ﹤0.01% 923
2025
Q2 		$142K Sell
5,132
-3,023
-37% -$79.6K ﹤0.01% 811
2025
Q1 		$231K Sell
8,155
-3,331
-29% -$118K ﹤0.01% 686
2024
Q4 		$478K Buy
11,486
+2,546
+28% +$122K ﹤0.01% 521
2024
Q3 		$597K Sell
8,940
-642
-7% -$58.9K ﹤0.01% 468
2024
Q2 		$1.14M Sell
9,582
-1,215
-11% -$154K ﹤0.01% 380
2024
Q1 		$1.15M Buy
10,797
+4,118
+62% +$415K ﹤0.01% 377
2023
Q4 		$664K Sell
6,679
-665
-9% -$55.9K ﹤0.01% 406
2023
Q3 		$759K Sell
7,344
-943
-11% -$105K ﹤0.01% 390
2023
Q2 		$1.01M Buy
8,287
+3,838
+86% +$512K 0.01% 375
2023
Q1 		$683K Buy
4,449
+2,357
+113% +$389K ﹤0.01% 400
2022
Q4 		$376K Buy
2,092
+999
+91% +$163K ﹤0.01% 494
2022
Q3 		$129K Sell
1,093
-906
-45% -$137K ﹤0.01% 663
2022
Q2 		$286K Sell
1,999
-1,235
-38% -$177K ﹤0.01% 540
2022
Q1 		$557K Buy
3,234
+1,358
+72% +$229K ﹤0.01% 522
2021
Q4 		$476K Buy
1,876
+343
+22% +$100K ﹤0.01% 591
2021
Q3 		$590K Buy
+1,533
New +$565K ﹤0.01% 564

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

CI Investments Inc's MRNA Position: Q2 2026 in Review

CI Investments Inc opened a new position in Moderna (MRNA) in Q2 2026: 12,208 shares worth $855K. The stake represents ﹤0.01% of the portfolio and ranks #563 among its holdings. This is a return to the name: CI Investments Inc previously reported a position in MRNA as recently as Q3 2025.

CI Investments Inc first reported a position in MRNA in Q3 2021 and has held it in 18 quarters since. The position peaked at $1.15M in Q1 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • CI Investments Inc held 12,208 shares of Moderna worth $855K as of Q2 2026.
  • Moderna was a new CI Investments Inc position in Q2 2026.
  • Moderna made up ﹤0.01% of CI Investments Inc's portfolio in Q2 2026, its #563 holding.
  • CI Investments Inc first reported a position in Moderna in Q3 2021 and has held it in 18 quarters since.
  • CI Investments Inc's Moderna position peaked at $1.15M in Q1 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.